New research findings and critical evaluation of existing data can lead to changes in screening and treatment of certain cancers. Here are some updates to the diagnosis and treatment of breast, uterine, and cervical cancers. Staying up-to-date on clinical guidelines is a must for care providers, as well as patients, but can be a challenge.…
The expression of MEG3 was downregulated in cervical intraepithelial neoplasia and squamous cell carcinoma tissues.
We may tend to think of our health-care system as a national program. In reality, the states and territories are responsible for delivering health-care services. That means local authorities are in charge of setting up health programs and sometimes opinions vary about what’s the best approach. As a result, cancer screening can differ from one…
What to know before you go to your annual gynecology appointment
“The good news is A, the HPV vaccine is likely to make a big impact on women, and B, the screening frequency is probably going to go down in the near future,”
Nobody ever really believes they could get a life-threatening illness when they’re young – we all somehow believe we’re invincible in our twenties and thirties, and even beyond. But in reality, that’s not the case. And while we don’t want to spend our lives worrying about something that might never happen, it can certainly pay…
When it comes to cervical cancer screening, most women receive a cytology-based Papanicolau (Pap) smear, where cells are scraped from the back of the cervix. However, human papillomavirus (HPV)-based testing may be a more accurate way of testing for cervical cancer, new study results suggest.1 Despite the widespread use of cervical cancer screening with a…
Histologically, CC can be characterized by two different sub-categories i.e. (i) invasive squamous cell carcinomas (ISCC) which are frequent and covers 85–90% of CC cases (ii) adenocarcinomas (ADC) which are relatively rare and comprises only 10–15% cases. The CC develops progression of precancerous lesions; called cervical intraepithelial neoplasia (CIN) grade 1–3 or squamous intraepithelial lesion (SIL).
Regeneron and Sanofi Share First Positive Clinical Data for Cemiplimab in Cervical Cancer at ASCO- New Drug on the Block Soon!
Source: https://www.onclive.com/onclive-tv/dr-ginsburg-discusses-global-vaccination-and-screening-for-cervical-cancer